Interestingly, while in normal cells, IGF-I typically binds to IGF-IR with (5–10-fold) higher affinity than IGF-II, glioma cells were shown to express a receptor with a unique IGF-IRα subunit of higher molecular size that has similar affinities for both ligands (29). The gene discussed is IGF2; the disease is central nervous system cancer.